GlaxoSmithKline PLC Director/PDMR Shareholding (8645S)
November 08 2019 - 11:22AM
UK Regulatory
TIDMGSK
RNS Number : 8645S
GlaxoSmithKline PLC
08 November 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mrs S Jackson
=== ======================== ===========================================
b) Position/status SVP, Global Communications & CEO Office
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the The sale of 1,158 Ordinary Shares, at a
transaction price of GBP17.2835 pursuant to a transfer
into an ISA.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP17.2835 1,158
----------
=== ======================== ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-11-08
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mrs S Jackson
=== ======================== ===========================================
b) Position/status SVP, Global Communications & CEO Office
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the The repurchase of 1,149 Ordinary Shares,
transaction at a price of GBP17.2937, to implement
a transfer into an ISA.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP17.2937 1,149
----------
=== ======================== ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2019-11-08
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================
a) Name Mr D Jackson
=== ======================== ================================================
b) Position/status PCA of Mrs S Jackson (SVP, Global Communications
& CEO Office)
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the The sale of 1,158 Ordinary Shares at a
transaction price of GBP17.2935 pursuant to a transfer
into an ISA.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP17.2935 1,158
----------
=== ======================== ================================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ================================================
e) Date of the transaction 2019-11-08
=== ======================== ================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ================================================
1. Details of PDMR/person closely associated with them
('PCA')
==========================================================================
a) Name Mr D Jackson
=== ======================== ================================================
b) Position/status PCA of Mrs S Jackson (SVP, Global Communications
& CEO Office)
=== ======================== ================================================
c) Initial notification/ Initial notification
amendment
=== ======================== ================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ==========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ================================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ==========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ================================================
b) Nature of the The repurchase of 1,150 Ordinary Shares
transaction at a price of GBP17.2905 to implement a
transfer into an ISA.
=== ======================== ================================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP17.2905 1,150
----------
=== ======================== ================================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ================================================
e) Date of the transaction 2019-11-08
=== ======================== ================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQVLFBKFFLFBB
(END) Dow Jones Newswires
November 08, 2019 11:22 ET (16:22 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
